Genetron Holdings Ltd. ADR (GTH): Price and Financial Metrics

Genetron Holdings Ltd. ADR (GTH): $3.92

0.00 (0.00%)

POWR Rating

Component Grades

Momentum

F

Stability

C

Sentiment

Quality

D

GTH Price/Volume Stats

Current price $3.92 52-week high $4.00
Prev. close $3.92 52-week low $2.08
Day low $3.91 Volume 19,800
Day high $3.94 Avg. volume 40,233
50-day MA $3.76 Dividend yield N/A
200-day MA $3.17 Market Cap 123.97M

GTH Stock Price Chart Interactive Chart >

GTH Stock Summary

  • With a year-over-year growth in debt of 84.01%, GENETRON HOLDINGS LTD's debt growth rate surpasses 90.74% of about US stocks.
  • The volatility of GENETRON HOLDINGS LTD's share price is greater than that of 96.72% US stocks with at least 200 days of trading history.
  • GENETRON HOLDINGS LTD's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is -67.25%, greater than the shareholder yield of just 6.23% of stocks in our set.
  • Stocks that are quantitatively similar to GTH, based on their financial statements, market capitalization, and price volatility, are IRBT, CTSO, FMC, NTGR, and AMST.
  • To dig deeper into the stock's financial statements, go to GTH's page on browse-edgar?action=getcompany&CIK=0001782594.

Genetron Holdings Ltd. ADR (GTH) Company Bio


Genetron Holdings, Ltd. engages in precision oncology. It provides cancer molecular profiling by using technologies in molecular biology and data science to transform cancer treatment. It products and services include diagnosis and monitoring through both LDT and IVD products. Its LDT portfolio consists of both specifically designed focused and comprehensive gene panel testing services. It also develops liver cancer early screening products. The company was founded by Si Zhen Wang, Hai Yan, and Wei Wu He in 2015 and is headquartered in Beijing, China.


GTH Latest News Stream


Event/Time News Detail
Loading, please wait...

GTH Latest Social Stream


Loading social stream, please wait...

View Full GTH Social Stream

Latest GTH News From Around the Web

Below are the latest news stories about GENETRON HOLDINGS LTD that investors may wish to consider to help them evaluate GTH as an investment opportunity.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

Pre-market stock movers are a hot topic among traders on Thursday and we're offering all of the latest coverage this morning!

William White on InvestorPlace | October 12, 2023

Genetron Health Enters into Definitive Merger Agreement for Going Private Transaction

BEIJING, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ: GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screening products and companion diagnostics development, announced today that it has entered into a definitive Agreement and Plan of Merger (the “Merger Agreement”) with New Genetron Holding Limited (“Parent”) and Genetron New Co Limited (“Merger Sub”), a

Yahoo | October 11, 2023

Genetron Health Announces Receipt of Notification from Nasdaq

BEIJING, May 23, 2023 (GLOBE NEWSWIRE) -- Genetron Holdings Limited ("Genetron Health" or the "Company", NASDAQ: GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screening products and companion diagnostics development, today announced that it has received written notification from the staff of the Listing Qualifications Department of the Nasdaq Stock Market LLC (“Nasdaq”) dated May 17, 2023, indicating that for the

Yahoo | May 23, 2023

Genetron Health Regains Compliance With Nasdaq Minimum Bid Price Requirement

BEIJING, Jan. 18, 2023 (GLOBE NEWSWIRE) -- Genetron Holdings Limited ("Genetron Health" or the "Company", NASDAQ: GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screening products and companion diagnostics development, today announced that the Company had received a notification letter (“Compliance Notice”) from the staff of the Listing Qualifications Department of the Nasdaq Stock Market LLC (“Nasdaq”), dated Jan

Yahoo | January 18, 2023

Read More 'GTH' Stories Here

GTH Price Returns

1-mo 3.43%
3-mo 6.81%
6-mo 36.64%
1-year 30.67%
3-year -94.69%
5-year N/A
YTD 6.52%
2023 9.52%
2022 -81.64%
2021 -56.43%
2020 N/A
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!